A Study of the Effects of Increasing Doses of a Drug for the Treatment of Nail Fungus

The purpose of this study is to determine an upper dose of albaconzole to be administered in a Thorough QTc study.

 

Condition Intervention Phase
Onychomycosis Drug: Albaconozole
Drug: Placebo		 Phase 1

 
Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Pharmacokinetics Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
Primary Purpose: Basic Science
Official Title: A Randomized, Double-Blind, Multiple-Dose, Placebo-Controlled Tolerability And Pharmacokinetic Study Of Escalating Doses Of Albaconazole In Healthy Subjects

Date of article/Start date of trial: 16 November 2009

Trial Phase: Phase 1

clinical Trials Gov ID: NCT01014962

Trial status: Completed

Back to New Antifungals